Czarnecka Karolina, Pastuszak-Lewandoska Dorota, Migdalska-Sek Monika, Nawrot Ewa, Brzezinski Jan, Dedecjus Marek, Pomorski Lech, Brzezianska Ewa
Department of Molecular Bases of Medicine, Medical University of Lodz, Lodz, Poland.
Front Biosci (Elite Ed). 2011 Jan 1;3(1):137-57. doi: 10.2741/e228.
In the present study the role of tumour suppressor genes (TSGs) hypermethylation and genetic instability of LOH/MSI type in thyroid tumorigenesis was assessed. Expression, methylation status and presence of LOH/MSI were analyzed for 8 TSGs selected from imprinted (IR) and non-imprinted (NIR) chromosomal regions in papillary thyroid carcinomas (PTCs) and nodular goitres (NGs). The results show that methylation-induced gene silencing occurs at an early step of thyroid carcinogenesis and involves multiple genes. Genetic changes of LOH/MSI type are less frequent. In PTC samples, the lack of significant differences in the frequency of LOH in IR and NIR suggests that it is not a key mechanism changing the pattern of gene expression. Co-methylation observed both in NG and PTC raises a possibility that, in thyroid tissue, methylation-induced silencing may occur not only in malignant transformation but also in functional context. We did not recognize any of the studied TSGs - in regard to aberrant methylation status or LOH/MSI frequency - as a selective molecular marker in thyroid tumorigenesis.
在本研究中,评估了肿瘤抑制基因(TSGs)高甲基化以及甲状腺肿瘤发生过程中LOH/MSI类型的基因不稳定的作用。分析了从乳头状甲状腺癌(PTCs)和结节性甲状腺肿(NGs)中印迹(IR)和非印迹(NIR)染色体区域选择的8个TSGs的表达、甲基化状态和LOH/MSI的存在情况。结果表明,甲基化诱导的基因沉默发生在甲状腺癌发生的早期阶段,且涉及多个基因。LOH/MSI类型的基因变化频率较低。在PTC样本中,IR和NIR中LOH频率缺乏显著差异,这表明它不是改变基因表达模式的关键机制。在NG和PTC中均观察到的共甲基化增加了一种可能性,即在甲状腺组织中,甲基化诱导的沉默不仅可能发生在恶性转化中,也可能发生在功能背景下。就异常甲基化状态或LOH/MSI频率而言,我们未将任何研究的TSGs识别为甲状腺肿瘤发生中的选择性分子标志物。